Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis

CJ Sarkisian, BA Keister, DB Stairs, RB Boxer… - Nature cell …, 2007 - nature.com
CJ Sarkisian, BA Keister, DB Stairs, RB Boxer, SE Moody, LA Chodosh
Nature cell biology, 2007nature.com
Activating Ras mutations can induce either proliferation or senescence depending on the
cellular context. To determine whether Ras activation has context-dependent effects in the
mammary gland, we generated doxycycline-inducible transgenic mice that permit Ras
activation to be titrated. Low levels of Ras activation—similar to those found in non-
transformed mouse tissues expressing endogenous oncogenic Kras2—stimulate cellular
proliferation and mammary epithelial hyperplasias. In contrast, high levels of Ras activation …
Abstract
Activating Ras mutations can induce either proliferation or senescence depending on the cellular context. To determine whether Ras activation has context-dependent effects in the mammary gland, we generated doxycycline-inducible transgenic mice that permit Ras activation to be titrated. Low levels of Ras activation — similar to those found in non-transformed mouse tissues expressing endogenous oncogenic Kras2 — stimulate cellular proliferation and mammary epithelial hyperplasias. In contrast, high levels of Ras activation — similar to those found in tumours bearing endogenous Kras2 mutations — induce cellular senescence that is Ink4a–Arf- dependent and irreversible following Ras downregulation. Chronic low-level Ras induction results in tumour formation, but only after the spontaneous upregulation of activated Ras and evasion of senescence checkpoints. Thus, high-level, but not low-level, Ras activation activates tumour suppressor pathways and triggers an irreversible senescent growth arrest in vivo. We suggest a three-stage model for Ras-induced tumorigenesis consisting of an initial activating Ras mutation, overexpression of the activated Ras allele and, finally, evasion of p53–Ink4a–Arf-dependent senescence checkpoints.
nature.com